Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 270.75%57.2M | 63.91%27.7M | 92.64%-3.6M | 71.94%47.8M | 49.83%-14.7M | -124.36%-33.5M | 425.00%16.9M | -179.64%-48.9M | -37.10%27.8M | -178.98%-29.3M |
| Net income from continuing operations | -502.66%-113.3M | -888.57%-34.6M | -550.94%-34.5M | -4,000.00%-12.3M | -228.87%-31.9M | 95.29%-18.8M | 98.97%-3.5M | 78.71%-5.3M | 93.62%-300K | 68.71%-9.7M |
| Operating gains losses | -0.42%-23.7M | 283.33%4.4M | 101.55%300K | -890.91%-17.4M | -168.29%-11M | 63.13%-23.6M | 97.65%-2.4M | -234.97%-19.3M | 116.67%2.2M | -111.11%-4.1M |
| Depreciation and amortization | -29.72%63.6M | -33.87%16.4M | -20.28%16.9M | -28.17%15.3M | -35.34%15M | -6.51%90.5M | -5.70%24.8M | -18.15%21.2M | -6.17%21.3M | 5.94%23.2M |
| Asset impairment expenditure | --0 | --0 | --0 | ---- | ---- | -104.72%-19.7M | -105.82%-24.3M | --4.6M | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---5M |
| Remuneration paid in stock | 442.86%3.8M | 140.00%600K | -21.43%1.1M | 360.00%1.3M | -38.46%800K | -88.89%700K | -50.00%-1.5M | -12.50%1.4M | -115.63%-500K | -48.00%1.3M |
| Deferred tax | -162.50%-4.2M | ---- | ---- | ---- | ---- | 96.86%-1.6M | 95.18%-1.6M | --0 | --0 | --0 |
| Other non cashItems | -14.66%62.3M | -18.93%13.7M | -20.32%14.9M | 0.57%17.5M | -19.00%16.2M | -26.71%73M | -47.68%16.9M | -16.14%18.7M | -27.20%17.4M | -5.21%20M |
| Change In working capital | 151.27%68.7M | 269.41%31.4M | 96.72%-2.3M | 452.85%43.4M | 93.67%-3.8M | -459.25%-134M | 1,314.29%8.5M | -334.00%-70.2M | -192.48%-12.3M | -1,032.08%-60M |
| -Change in receivables | 270.80%19.3M | ---- | ---- | ---- | ---- | -115.35%-11.3M | ---- | ---- | ---- | ---- |
| -Change in inventory | 400.85%35.5M | ---- | ---- | ---- | ---- | 68.36%-11.8M | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | -293.55%-12M | ---- | ---- | ---- | ---- | 210.00%6.2M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 122.12%25.9M | ---- | ---- | ---- | ---- | -11,610.00%-117.1M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 270.75%57.2M | 63.91%27.7M | 92.64%-3.6M | 71.94%47.8M | 49.83%-14.7M | -124.36%-33.5M | 425.00%16.9M | -179.64%-48.9M | -37.10%27.8M | -178.98%-29.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -98.06%5.7M | -1,333.33%-3.7M | -161.97%-4.4M | 27.27%-8M | -92.66%21.8M | 1,951.75%293.4M | -99.88%300K | 107.86%7.1M | 78.81%-11M | 398.19%297M |
| Capital expenditure reported | 49.67%-22.6M | 40.18%-6.7M | -89.74%-7.4M | 77.42%-4.9M | 55.56%-3.6M | 84.65%-44.9M | 78.13%-11.2M | 90.08%-3.9M | 77.40%-21.7M | 92.37%-8.1M |
| Net business purchase and sale | ---1.2M | --0 | ---1.2M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Net other investing changes | -91.28%29.5M | -73.91%3M | -61.82%4.2M | -128.97%-3.1M | -91.67%25.4M | -4.35%338.3M | --11.5M | 121.57%11M | -75.96%10.7M | 4,593.85%305.1M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -98.06%5.7M | -1,333.33%-3.7M | -161.97%-4.4M | 27.27%-8M | -92.66%21.8M | 1,951.75%293.4M | -99.88%300K | 107.86%7.1M | 78.81%-11M | 398.19%297M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 76.18%-61.9M | -45.35%-25M | -75.50%9.8M | -45.59%-39.6M | 97.22%-7.1M | -54.06%-259.9M | 93.24%-17.2M | 325.53%40M | -196.11%-27.2M | -632.29%-255.5M |
| Net issuance payments of debt | 90.86%-19.2M | -829.41%-12.4M | -66.60%16.5M | -17.50%-23.5M | 100.08%200K | -187.67%-210M | 100.76%1.7M | 50.61%49.4M | -136.70%-20M | -472.64%-241.1M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | 1,100.00%1M | --0 | 1,400.00%1.3M | --100K | ---400K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 15.64%-46.4M | 16.18%-11.4M | 33.33%-11M | -11.01%-12.1M | 15.00%-11.9M | 30.03%-55M | 45.82%-13.6M | 13.16%-16.5M | 50.45%-10.9M | -12.00%-14M |
| Net other financing activities | -9.76%3.7M | 77.36%-1.2M | -25.86%4.3M | -211.11%-4M | --4.6M | --4.1M | ---5.3M | --5.8M | --3.6M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 76.18%-61.9M | -45.35%-25M | -75.50%9.8M | -45.59%-39.6M | 97.22%-7.1M | -54.06%-259.9M | 93.24%-17.2M | 325.53%40M | -196.11%-27.2M | -632.29%-255.5M |
| Net cash flow | ||||||||||
| Beginning cash position | 0.00%100K | 2,000.00%2.1M | -84.21%300K | -99.19%100K | 0.00%100K | -99.41%100K | -97.22%100K | -91.77%1.9M | 392.00%12.3M | -99.41%100K |
| Current changes in cash | --1M | ---1M | 200.00%1.8M | 101.92%200K | ---- | ---- | ---- | 90.77%-1.8M | -150.49%-10.4M | 184.14%12.2M |
| End cash Position | 1,000.00%1.1M | 1,000.00%1.1M | 2,000.00%2.1M | -84.21%300K | -99.19%100K | 0.00%100K | 0.00%100K | -97.22%100K | -91.77%1.9M | 392.00%12.3M |
| Free cash from | 144.13%34.6M | 268.42%21M | 79.17%-11M | 603.28%42.9M | 51.07%-18.3M | 49.45%-78.4M | 110.11%5.7M | -338.91%-52.8M | 111.78%6.1M | 45.80%-37.4M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.